BioSpace News Archive

Welltok, the leading consumer health enterprise SaaS company, announced today that it will present at the annual J.P. Morgan Healthcare Conference Tuesday, January 14, 8:00 a.m. PT at the San Francisco Westin St. Francis Hotel in Elizabethan C.

The Journal of Electrocardiology has published a study showing unparalleled accuracy in non-invasive coronary artery disease (CAD) detection using Cardisio’s new low-cost method which involves no radiation exposure.

As the American healthcare industry shifts from fee-for-service to a value-based model, effective and sustained patient engagement is critical.

SHINE Medical Technologies LLC today provided a strong 2019 year-end report, including significant progress with the construction of its medical isotope production facility, a robust year of fundraising and commercial advances in key geographic and product markets.

AmpliVox Sound Systems’ CEO Don Roth has pledged to personally match the first $500 in donations made in the month of January, 2020 to the “Ocular Melanoma Research in Memory of Nancy Roth” GoFundMe fundraiser.

Remaro Group, Inc. (OTC:REMO) (“Company”), a Nevada corporation, announced today that it consummated an Agreement and Plan of Share Exchange (“Exchange Agreement”) with Boomer Naturals Holdings Inc., holding company for the Boomer Naturals brand (“Boomer”), a health and wellness company headquartered and organized in the state of Nevada.

Concerto HealthAI, a market leader for Real-World Data (RWD) and enterprise AI technology solutions for Precision Oncology, announced today that it has entered into a multi-disease collaboration with Janssen Research & Development, LLC (Janssen).

Medvantx, Inc., a leading provider of ecommerce pharmacy and final-mile delivery solutions, today announced a major expansion and technology upgrades of its embedded, end-of-runway pharmacy at the UPS Supply Chain Solutions campus in Louisville, KY.

Bronchiolitis, a lung infection that is one of the most common reasons for hospitalizations in young children, is most prevalent during the winter months and is usually treated with albuterol delivered via inhalers, despite evidence showing no benefit in most patients.

InterVenn Biosciences today announced multiple achievements in its development of AI-enabled glycoproteomics, as it looks to solving difficult challenges in various disease areas of unmet medical need